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Introduction
Non-rational use of drugs is a problem, which 
already existed for a long time in the clinical practice 
in human and veterinary medicine. Although this 
issue was on many occasions subject of discussion 
on numerous Symposiums and Congresses, it is still 
very current, maybe even more than before. First of 
all, such use of drugs can easier cause certain harmful 
effects and damages in treated animals. Bearing 
this in mind, and also the fact that there aren’t any 
signiﬁcant improvements in the clinical practice, we 
must devote much more time and attention to follow 
and control use of drugs on animals (Ćupić and 
Živanov, 1990). 
Non-rational use of drugs in veterinary medi-
cine, as well as the need for control of their use 
becomes even bigger problem when used on food 
producing animals. In that case, there is the possi-
bility that minimal quantities of drugs and their me-
tabolites (residues) which remain in edible tissues, 
i.e. in animal products (meat, milk, eggs, honey) 
induce certain harmful effects in people as potential 
consumers of such food (Ćupić, 1997). 
We are witnesses that productivity in food pro-
ducing animals has manifold increased during the 
last 50 years, ﬁrst of all due to improvement of sele-
ction, veterinary-medical care, as well as improve-
ment of diet and good organization of production. 
With the help of these measures, which are perma-
nently corrected and amended, even in the countries 
where they were brought to the perfection), animals 
became “real small factories“ for production of food. 
Simultaneously with attaining of higher productivity 
of animals, the need for the decrease of their number 
occurred. Actually, only animals whose keeping is 
economic proﬁtable in production are retained.
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Evidence of increase of animal productivity 
over time can be illustrated in the following exam-
ple: in 1928 year, in poultry rearing (broilers), in 
order to reach the commercial weight of 1,7 kg per 
unit, 112 days were necessary and birds needed to 
consume about 22 kg of food, in average; in 1990, 
broiler reach the weight of 2 kg in 42 days by con-
suming only 4 kg of food per one unit/animal. In the 
1930-ties, hens laid 93 eggs per year, in the 1950-ties 
174, and in 1993 252 eggs yearly.
Similar example exists in production of cow 
milk. In USA, for example, with the decrease of dai-
ry cows, there was the increase of milk production, 
due to the increase of milk yield per cow. In compa-
rison to year 1983, when milk yield in USA amount-
ed to 5.598 kg/cow in average, in 1995, milk yield 
increased to 7.478 kg/cow, etc. 
One of measures, which besides others, no do-
ubt, contributed to higher the productivity of animals 
was veterinary-medical care in animal production. 
First of all, it is reﬂected in the efﬁciency of preventi-
on of different animal diseases, and understanding of 
the use of different vaccines and others prophylactic 
remedies. Also, not less signiﬁcant was the role of 
antibiotics, i.e. antimicrobial drugs and anti-parasitic 
drugs, which are used mainly in therapy, but also for 
prevention of diseases, as well as drugs which are 
used as growth stimulators, among which the most 
frequent are hormones and some antimicrobials 
(Adams, 2001; Brander et al., 1991). 
The use of antimicrobial drugs in animals at-
tracts special attention. In therapy of diseases of 
bacterial etiology they are certainly indicated and in 
those kinds of cases their use is justiﬁed, it is better to 
say rational, regardless of all hazards due to residues 
of these drugs in food stuffs consumed by humans 
(Giguere et al., 2006).
Namely, it is considered that damage in untre-
ated animals could be much higher, than short-term 
inability to use food stuffs (obtained from such 
animals) in determined period subsequent to thera-
py, depending on the withdrawal period. Prophy-
lactic use of antimicrobial drugs or use of these 
drugs for the purpose of growth stimulation in ani-
mals understands giving of smaller doses than the-
rapeutic of antimicrobial drugs. Thereby, with this 
kind of drug use, the risk from incidence of diseases 
bacteria etiology is decreased and utilization of 
food improved and growth stimulated. However, 
subsequent to such use of antimicrobial drugs si-
multaneously the risk of incidence of undesirable 
effects increases considerably. First of all, rate of 
development of resistance of bacteria to used anti-
microbial drugs is increased (Ašanin et al., 2005) 
and certainly risk from residues in animal food stuffs 
intended for human consumption is higher than 
when antimicrobials are used only in therapeutic 
purposes (Sanders, 2007; Spirić et al., 2007). Beca-
use of this reason, in our country, maximum care is 
taken so that antimicrobials are not used in prophy-
lactic purposes, but only in therapeutic, as well as 
that they are not used for stimulation of growth in 
animals (Ćupić et al., 1997).
Rational use of antimicrobial drugs 
Nowadays, in the clinical practice of human 
and veterinary medicine throughout the world a large 
number of antimicrobial drugs are used. Likewise 
many scientists intensively work on discovery and 
synthesis of new drugs with broader antimicrobial 
spectrum, stronger action and more satisfactory safe-
ty proﬁle. Unfortunately we are witnesses of rather 
non-rational use of these drugs. Despite constant 
indicating of all failures and harmful effects of such 
use, it is present in every-day clinical practice.
Most mistakes during antimicrobial therapy 
may occur when pathogenic microorganism is un-
known and therapy starts empirically. Most often 
combinations of two or more antibiotic drugs are 
used. To avoid these mistakes, clinically conﬁrmed, 
effective antibiotic combinations should be used. 
These combinations are useful in treating serious 
infections, mixed bacterial infections, when resistance 
occurs enzymatic destruction of a drug, and in order 
to reduce toxicity (Giguere et al., 2006). 
Unwanted effects of antimicrobial drugs
Unwanted effects of antimicrobial drugs can 
be quite mild and pass in a form of quite slight 
disturbances, then also unexpected reactions may 
appear, (such as idiosyncratic or allergic reactions, 
even anaphylactic shock), as well as different da-
mages to the function of organs. Sometimes, non-
rational use of drugs, can provoke the most serious 
disturbances, as are mutagenesis, carcinogenesis and 
teratogenesis. Because of all of this, today, in clini-
cal practice we must be very careful and consider 
frequency of application and dose of these drugs, 
and also possible side effects, which some of these 
drugs can provoke, and especially in case of those 
drugs which are banned (because of proved toxicity), 
(Ćupić and Živanov, 1990; Giguere et al., 2006; 
Ćupić and Dobrić, 2003).
Forbidden antimicrobial and other drugs for 
use in food producing animals
Because of their toxicity, for animals alone 
(to whom they are applied), and also for people, 
potential consumers of products, which derived from 
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such animals, Food and Drug Administration (FDA) 
banned the use of some antimicrobials, as well as 
other drugs in food animals. Those are: chloramphe-
nicol, nitroimidazoles, nitrofurans, quinoxalines, 
ﬂuoroquinolones, sulfonamides, glycopeptides, iono-
phors, cephalosporins, diethylstilbestrol, dypirone, 
phenylbutazone, clenbuterol and some antiviral 
drugs in poultry (Payne et al., 1999; Davis et al., 
2009).
Some of the mentioned drugs (majority) 
FDA prohibited completely, and some of them are 
prohibited as extra label drugs, which means that 
when a drug is used in a manner that is not in ac-
cordance with the FDA approved label, or Instru-
ction. This includes use in a species or for a disease 
or condition not listed on the label; use at dosages, 
frequencies or routes of administration that differ 
from those stated on the label; or deviation from the 
labeled withdrawal time. According to AMDUCA 
(Animal Medicinal Drug Clariﬁcation Act) from 
the year 2010, all of the aforementioned drugs now 
are completely prohibited for use in food animals 
(AMDUCA, 2010).
Chloramphenicol - This drug is forbidden since 
the year 1984, because it can cause (although rarely) 
idiosyncratic (non dose dependent, irreversible) apla-
stic anemia in people. Likewise, the use of all pre-
parations including ophthalmic ointments, or spray 
for wounds in food producing animals is forbidden. 
However, the newer members of amphenicols like 
ﬂorfenicol or tiamfenicol are allowed. Florfenicol is 
available for use in cattle, swine, and some aquatic 
species (Davis et al, 2009; Payne et al., 1999). 
Nitroimidazoles - All members of this group 
(including dimetridazole, metronidazole, ronidazo-
le, tnidazole and ipronidazole) are forbidden because 
of their in vitro and in vivo carcinogenic properties. 
Although they are used in humans and companion 
animals, the use of any drug from this group in food 
producing animals is illegal (Payne et al., 1999). 
Nitrofurans - These drugs are also forbidden 
because of carcinogenicity and mutagenicity (Payne 
et al., 1999; Batas et al., 2007). The use of these 
drugs for therapy of systemic infections in human 
medicine was withdrawn in 1974 and for treatment 
of systemic infection in veterinary medicine was 
banned in 1991. Later studies have documented that 
topical application of these drugs for therapy of eye 
or surface wounds in cattle, sheep and goats, also 
results in milk and meat residues. Because of that, 
FDA prohibited the use of topical nitrofurans in-
tended for human and veterinary medicine in food 
producing animals (Smith et al., 1998). Since year 
2002, all systemic and topical use of nitrofuran pro-
ducts has been prohibited (US FDA Web site, 2009). 
Quinoxalines - It has been known for a long 
time that quinoxalines (carbadox, olaquindox and 
cydox) are carcinogenic compounds. Because of 
that, many countries have forbidden or withdrawn 
these drugs from use (Payne et al., 1999). 
Fluoroquinolones - These drugs became inte-
resting, because it was shown that they stimulate 
development of bacterial resistance. The best instan-
ce are resistant salmonellosis infections in humans. 
Therefore, the use of ﬂuoroquinolones intended for 
humans is banned since 1997, as well as their use in 
food producing animals. So, the use of enroﬂoxacin 
is banned in all food producing animals, except in 
calves and heifers. Precisely this drug may not be 
used in cows in period of lactation or dry period, 
heifers, dairy calves, ewes, goats and deer. Also, 
because of that, enroﬂoxacin may not be stored in 
dairy farm drug cabinets (Payne et al., 1999). 
Sulfonamides - Sulfonamides have been ban-
ned in adult dairy cows. Adult dairy cows are de-
ﬁned as any dairy cow over 20 months of age, 
regardless of milking status. This ban was instituted 
because of the concern over carcinogenic effects 
detected in laboratory animals, which coincided 
with reports of sulfonamide residues detected in 
up to 73% of commercial milk samples. Only 1 of 
the 3 sulfonamides that have label indications for 
lactating cows, sulfadimethoxine (SDM) is currently 
being marketed. Currently, use of any sulfonamide 
other than SDM in dairy cattle older than 20 months 
is illegal. Additionally, extralabel use of SDM in 
lactating dairy cattle is prohibited (for example use 
of a higher dose or slow-release SDM boluses in 
dairy cattle is not permitted), (Payne et al., 1999; 
Davis et al, 2009).
Glycopeptides - The only glycopeptide anti-
biotic available in the United States is the human 
product vancomycin. Vancomycin is often used for 
the treatment methicillin-resistant Staphylococcus 
aureus infections in humans. Avoparcin, a compound 
chemically similar to vancomycin, has been used in 
European animal feeds as a growth promoter since 
the mid 1970s. FDA in 1977 issued an order prohi-
biting the extra label use of all glycopeptides in food 
producing animals. The restriction of ﬂuoroquino-
lone and glycopeptide use represents a novel exerci-
se of FDA discretionary authority: restriction based 
not on the drugs direct toxicity, but on its potential 
for increasing human pathogen resistance (Jung et 
al., 2007; Klare et al., 2003; Song et al., 2005). 
Ionophors- The use of ionophore antibiotics 
such as monensin and lasalocid is banned in lactat-
ing dairy. This is valid also for ewes and goats in 
period of lactation (Payne et al., 1999).
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Cephalosporins - In July 2008, FDA proposed 
prohibition on extra label use of cephalosporins in 
food producing animals, because of the increased 
incidence of cephalosporin-resistant food-borne 
pathogens, particularly Salmonella spp. Monitoring 
system revealed an increase in resistance of Sal-
monella isolates from both humans and food- 
-producing animals to ceftiofur, a member of third- 
-generation cephalosporin drug marketed for use 
in cattle, sheep, dairy goats, and swine as multiple 
injectable formulations as well as intramammary 
preparations for lactating and non-lactating cows 
(US FDA Web site, 2009). 
Diethylstilbestrol - This drug is forbidden in 
food producing animals since 1979, because of its 
carcinogenic potential. Namely, it was recorded 
that in pregnant women it provokes development 
of reproductive tract abnormalities and tumors in 
female offspring of diethylstilbestrol treated patients 
(Newbold, 2008).  
Dipyrone- It is known that dipyrone is drug 
which belongs to the large group of Nesteroidal- 
-anti-inﬂammatory drugs. However, it was recorded 
that this drug, in addition to the anti-inﬂammatory, 
antipyretic and analgesic action, also induces very 
toxic effects in humans (non-dose dependent terra-
togenic effects, prolonged bleeding times and agra-
nulocytosis). Because of that FDA abolished its use 
and withdrew this drug from the market in 1977, 
while its use in the veterinary medicine was ﬁrst 
abolished in small non-food-producing animals in 
1995, with suggestion that this must be instituted 
in all food-producing animals also. Today, use of 
dypirone in any food producing animal is considered 
illegal (Center for food Safety and Applied Nutrition 
Web Site, 2009).
Phenylbutazone - Phenylbutazone (as sulfona-
mides) in dairy cattle over 20 months of age was 
prohibited in 2003. This was based on detection of 
phenylbutazone residues in culled dairy cattle and 
the discovery of phenylbutazone products on dairy 
farms. It is considered that phenylbutazone in hu-
mans can induce blood dyscrasis (such as aplastic 
anemia, leucopenia, agranulocytosis and thrombocy-
topenia) and cause death. It is also considered a car-
cinogen. Because of that, currently phenylbutazone 
use is strictly prohibited only in dairy cattle over 20 
months of age (New animal drugs, 2003).    
Clenbuterol - This drug is known bronchodila-
tator which acts on the β-adrenergic receptors 
in bronchial tree. As that kind of drug, its use is 
allowed in horses, but in cattle and sheep it can 
provoke relaxation of uteri miometrium. Also, it has 
secondary anabolic effects. Because of this anabolic 
effect it was used illegally for stimulation of growth 
in food animals intended for humans, and for increa-
se of lean body mass and weight gain in humans. 
However, in order to attain these effects, high doses 
of this drug are needed. High doses usually provoke 
adverse effects in humans. There are reports from 
Spain, France, Italy, Portugal and other countries in 
humans who consumed liver of treated cattle and 
lambs, and many people were hospitalized, and 
some of them died (Payne et al., 1999; Salleras et al, 
1995; Barbosa et al., 2005; Brambilla et al., 2000).
Antiviral drugs in poultry - Two classes of 
antiviral drugs currently marketed for use in humans 
have been added to the list of prohibited drugs in 
poultry (US FDA Web Site, 2009). These are the 
adamantine inhibitors, rimantadine and amantadine, 
as well as the neuraminidase inhibitors, oseltamivir 
and zanamivir. These antiviral drugs have been used 
in countries outside the United States to treat or 
prevent the development and spread of avian inﬂu-
enza in poultry. The prohibition extends speciﬁcally 
to chickens, turkeys, and ducks. The prohibition 
order is based on the potential for the development 
of resistance to these compounds (Parry, 2005; He 
et al., 2008; Cyranoski, 2005).
Forbidden antimicrobial drugs for use in 
food animals (present situation in Serbia)
According to the proposal of the Medicines 
and Medical Devices Agency, (published in Ofﬁ-
cial Journal, No. 96/09), the following antimicro-
bial drugs are prohibited in Republic of Seriba: 
quinaxalines, nitrofurans, nitroimidazoles, glycope-
ptides, sulfonamides in adult dairy cows, ﬂuoroqu-
inolones) (Ofﬁcial Journal of RS, 2009). 
Conclusions
When drugs are used in animals which are 
intended for humans, then there is possibility for 
producing adverse effects in humans as potential 
consuments of food, orginating from treated ani-
mals. To prevent this possibility it is necessary to 
rationally use drugs, i.e. to use them only when 
they are really indicated, in the right way, right 
time and in the right dose. Also, it should respect 
withdrawal period, permanently follow, register and 
announce all about adverse effects after use of  any 
drug, regularly control sensibility of bacteria to anti-
microbial agents, and regularly control residues of 
antimicrobials common used in clinical practice. 
Finally, having in mind that our country is in 
transition, and aspiring to become EU member, as 
soon as possible justiﬁes further discussions and 
studies of this topic. 
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Značaj racionalne primene lekova u veterinarskoj 
medicini za bezbednost hrane
Ćupić Vitomir, Dobrić Silva, Antonijević Biljana, Čelebićanin Sanja
R e z i m e: Racionalna primena lekova u veterinarskoj medicini ima višestruk značaj. Korišćenjem lekova samo kada 
su stvarno neophodni (indikovani), u pravoj dozi i na pravi način, smanjuje se potencijalna šteta od njihovog korišćenja, a 
ujedno se povećava delotvornost, i smanjuje rizik od nastanka rezistentnosti mikroorganizama (odnosi se na antimikrobne 
lekovei). Sve navedeno postaje još važnije kada se veterinarski lekovi koriste u lečenju farmskih životinja, odnosno životinja 
čiji se proizvodi koriste za ishranu ljudi. 
Istovremeno sa intenziviranjem stočarske proizvodnje i povećanjem produktivnosti životinja, povećava se i broj lekova 
koji se koriste. Danas ne postoji skoro nijedna životinja, u intenzivnom, kao i ekstenzivnom uzgoju, koja nije primila barem 
jedan lek tokom svog života. 
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U živinarstvu, govedarstvu i svinjarstvu, kao glavnim sektorima gde se proizvode prehrambeni proizvodi životinjskog 
porekla, upotreba lekova je dostigla granice koje se mogu smatrati alarmantnim za zdravlje ljudi. 
Na prvom mestu su antibiotici, ili antimikrobni lekovi, koji se veoma često koriste u terapiji ili prevenciji bakterijskih 
bolesti, a ne tako retko i kao promotori rasta. Osim antibiotika, koriste se i mnogi drugi lekovi, koji imaju dokazano štetno 
dejstvo, pa čak i kancerogene ili teratogene osobine/svojstva. Njihove rezidue u proizodima životinjskog porekla koji se koriste 
u ljudskoj ishran, mogu veoma ozbiljno da ugroze zdravlje ljudi, koji su potencijalni konzumenti ove vrste hrane. Zbog toga je 
kontrola primene antimikrobnih lekova, kao i ostalih lekova u stočarstvu, od izuzetne važnosti. 
Ključne reči: neracionalna primena lekova, antimikrobni lekovi, neželjeni efekti, životinje čiji se proizvodi koriste za 
ishranu ljudi.
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